企業プロフィール
Medpace 株価・ニュース・カタリスト
- ティッカー:
- MEDP
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
597.12 USD (+3.22%)
終値
最終更新: 2026年8月17日
12.7B USD
時価総額
株価変動の要因
As of Aug 17, 2026, MEDP closed up 3.22% at $597.12. No new same-company headline was identified in the current news window.
企業概要
Full-Service Clinical Research
Medpace is a global contract research organization providing Phase 1 through Phase 4 clinical-development services to biotechnology, pharmaceutical and medical-device companies.
Therapeutic and Scientific Expertise
The company uses physician leadership and therapeutic-area specialists to support protocol design, regulatory planning, trial execution and data interpretation. This scientifically driven model is particularly relevant for emerging biotechnology sponsors with limited internal development infrastructure.
Integrated Trial Operations
Medpace offers project management, clinical monitoring, data management, biostatistics, medical writing, safety and laboratory services through an integrated operating model. Its global network allows sponsors to run multinational studies with a single primary CRO.
今後のカタリスト
- Medpace’s watchlist is backlog conversion, study-start momentum, and how biotech funding trends affect CRO demand. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。